PPT-Clinical needs and technical requirements for ventilators for COVID-19 treatment critical

Martina Andellini martinaandelliniwarwickacuk University of Warwick Coventry UK martinaandelliniopbgnet Bambino Gesù Childrens Hospital Rome Italy The Team Leandro Pecchia . COVID-19 Clinical GuidanceFor the CVCare Team1COVID-19Clinical Guidance For the Cardiovascular Care TeamNoteCOVID-19 is a quickly evolving public health emergency The guidance provided in this documen 1Children MIS-C Associated with SARS-CoV-2 and Hyperinflammation in COVID-19Developed by the ACR MIS-C and COVID-19 Related Hyperinflammation Task ForceThis summary was approved by the ACR Board of Di GuidingfromtheAmericanCollegeofRheumatologyforScarceResourceAllocationDuringtheCOVID-19PandemicTheCaseofHydroxychloroquineBackgroundEthicalprinciplesmustbebalancedwhenmakingdecisionsaboutscarceresourc Andreas J . Deymann. , MD. Chair of the Department of Pediatrics . Memorial Hospital South Bend. Justin Chow, MD, FACP, . FHM. Hospitalist. Director . of Mid-Level Program of Hospitalist Department. Memorial Hospital South Bend. Lifesaving treatment and clinical operations. Vikram. Mukherjee, MD. Director, Medical ICU, Bellevue Hospital Center. Director, Special Pathogens Program, Bellevue Hospital Center. Clinical aspects: overall impressions so far. Paul Reynolds, PharmD, BCCCP. Matthew Miller, PharmD, BCIDP. Gina Moore, PharmD, MBA. March 20, 2020. Learning Objectives. Identify the unique clinical and epidemiological characteristics of Coronavirus (COVID-19) in the spectrum of viral clinical illnesses and previous Coronavirus (SARS, MERS) and non-Coronavirus (influenza, common cold) related illnesses. Version 4.0 11/07/2022 1 | Page Prioritisation of COVID - 19 Medications Prepared by Department of Health, Western Australia. V ersion 4.0 9 AUG 2022 Medicines and Technology Unit Version 4.0 1 . www.hse.ie/coronavirus. www.hpsc.ie. 15. th. . March 2020. AIM. This presentation aims to provide clinicians with interim guidance on timely, effective, and safe supportive management of patients with COVID-19, including . Mark . Sonderup and Douglas LaBrecque*. Division of Hepatology, Department of Medicine, . University of Cape Town and Groote Schuur Hospital. Cape Town, South . Africa. *Emeritus Professor of Internal Medicine, Gastroenterology and Hepatology. M. Safwan Badr, MD, MBA. Professor and Chair, Department of Internal Medicine. Wayne State University School of Medicine.. Pathophysiology of COVID. Coronaviruses. Large, enveloped, single-stranded RNA viruses found in humans and other mammals. Raj Dasgupta MD, FACP, FCCP, FAASM. Associate Professor of Clinical Medicine. Assistant Program Director of Internal Medicine Residency. Associate Program Director of Sleep Medicine Fellowship. Department of Pulmonary / Critical Care / Sleep Medicine. Speakers. Dr Jonathan . Grein. - . Cedars-Sinai Medical Center, L.A.. Dr Shariq Haider- McMaster University. Moderator. Dr Curtis Cooper- University of Ottawa. Our Mission. The Canadian Foundation for Infectious Diseases is a charitable organization committed to improving the health of Canadians and people worldwide through the support of research and dissemination of knowledge pertaining to the prevention, diagnosis, control and treatment of infectious diseases.. This webinar is being recorded and will be posted to the CTTI website. All participants are muted upon entry. Questions can be entered in the chat box during the webinar. Questions will be answered to the best of our ability after the call via CTTI’s best practices document. Adapted. . from a talk by:. Rajesh T. Gandhi, MD . Massachusetts General Hospital. Professor of Medicine, Harvard Medical School. Jason C. Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS. Clinical Professor, Temple University.